COVID-19'lu Yaşlı Bireylerde Başlangıçtaki Hasta Özelliklerinin Kısa ve Uzun Dönem Genel Mortalite Üzerindeki Etkisi: Retrospektif Kohort Çalışması

Yıl 2024, Cilt: 7 Sayı: 2, 83 - 92, 31.08.2024

Özge Aydın Güçlü , Nilüfer Aylin Acet-öztürk , Dilara Ömer Topçu , Orkun Eray Terzi , Uğur Önal , Ezgi Demirdöğen , Asli Gorek Dilektasli , Dane Ediger , Funda Coşkun , Ahmet Ursavaş , Esra Uzaslan , Halis Akalın , Mehmet Karadağ

https://doi.org/10.47141/geriatrik.1460339

Öz

Amaç: Yaşlı insanlar yaşlanma ve altta yatan potansiyel sağlık koşullarına bağlı olarak ortaya çıkan fizyolojik değişiklikler nedeniyle daha sık COVID-19 ile karşılaşmaktadır. Çalışmamızda pandemi polikliniğine başvuran, genç-yaşlı, orta-yaşlı ve ileri-yaşlı olarak sınıflandırılan 65 yaş ve üzeri yaşlı hastalarda hastaneye başvuru semptom ve bulgularının kısa ve uzun vadeli mortalite üzerindeki etkisinin değerlendirilmesi amaçlanmıştır.

Gereç ve Yöntemler: Acil servise başvuran semptomatik hastalar çalışmaya dahil edildi. Başvuru anında demografik veriler, semptomlar, komorbiditeler, toraks bilgisayarlı tomografi (BT) ve laboratuvar bulguları kaydedildi. Primer sonlanım noktası tüm nedenlere bağlı kısa dönem (altı ay içinde) ve uzun dönem (dört yıl içinde) ölümlerdi.

Bulgular: Araştırmaya yaş ortalaması 67,4±9,8 yıl olan ve %52,2’si erkek olan 393 hasta dahil edilmiştir. Son dört yıldaki ölüm oranlarına bakıldığında kısa dönemde 72 (%18,3) vakanın, uzun dönemde ise 104 (%26,5) vakanın öldüğü belirlendi. Kronik böbrek yetmezliği (KBY), koroner arter hastalığı (KAH), orta-yaşlı ve ileri-yaşlı hastaların 50-64 yaş grubuyla karşılaştırıldığında genel kısa dönem mortalitenin bağımsız belirleyicileri olduğu bulundu. Erkek cinsiyet, KAH, malignite, KBY, ateş ve nefes darlığı semptomları ile 50-64 yaş grubu ile karşılaştırıldığında genç-yaşlı, orta-yaşlı ve ileri-yaşlı olguların genel uzun dönem mortaliteyi bağımsız olarak öngördüğü belirlendi.

Sonuç: İleri yaş, erkek cinsiyet, nefes darlığı ve ateş semptomları, yüksek D-dimer düzeyleri, KAH, malignite ve KBY varlığı yaşlılarda daha yüksek COVID-19 enfeksiyonu kısa ve uzun dönem ölüm riski ile ilişkiliydi.

Anahtar Kelimeler

Yaşlı Hasta, COVID-19, Laboratuvar, Radyoloji, Semptomlar, Mortalite

Impact of Baseline Patient Characteristics on Short- and Long-Term Overall Mortality in Elderly Patients with COVID-19: A Retrospective Cohort Study

Öz

Aim: Elderly people encounter COVID-19 more frequently due to physiological changes associated with aging and underlying potential health conditions.The study aims to evaluate the impact of baseline patient characteristics on short- and long-term mortality in elderly patients aged 65 and over, classified as youngest-old, middle-aged, or oldest-old, who applied to the pandemic outpatient clinic and had not yet been vaccinated.

Materials and Methods: Symptomatic patients who attended the emergency department were enrolled in the study. Demographic data, symptoms, comorbidities, thoracic computed tomography (CT), and laboratory results were recorded at admission. The primary outcomes were all-cause short-term (within six months) and long-term (within four years) mortality.

Results: The study consists of 393 participants, with a mean age of 67.4 ± 9.8 years and 52.2% male. Considering the death rates in the last four years, it was determined that 72 (18.3%) cases died in the short term, and 104 (26.5%) cases died in the long term. It was found that chronic renal failure (CRF), coronary artery disease (CAD), middle-old and oldest-old-aged patients compared to the 50-64 age group were independent predictors of overall short-term mortality. It was determined that the following factors independently predicted overall long-term mortality: male gender, CAD, malignancy, CRF, fever, and dyspnea symptoms, and the patients of the youngest-old, middle-old, and oldest-old relative to the 50–64 age group.

Conclusion: Advanced age, male gender, symptoms of shortness of breath and fever, high D-dimer levels, the presence of CAD, malignancy, and CRF were related to a higher risk of death from COVID-19 infection in the elderly.

Anahtar Kelimeler

Elderly Patients, COVID-19, Laboratory, Radiology, Symptoms, Mortality

Kaynakça

• Mohan B, Nambiar V. COVID-19: an insight into SARS-CoV-2 pandemic originated at Wuhan City in Hubei Province of China. J Infect Dis Epidemiol 2020; 6: 146.
• Wu C, Chen X, Cai Y et al. Risk factors associated with acute respiratory distress syndrome and death in pa-tients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medi-cine 2020; 180: 934-943.
• https: / / covid19.saglik.gov.tr / . , Erişim tarihi: 18 Mart 2022
• https: / / www.who.int / health-topics / ageing#tab=tab_1, Erişim tarihi: 18 Mart 2022
• https: / / data.tuik.gov.tr / Bulten / Index?p=Elderly-Statistics-2021-45636&dil=2., Erişim tarihi: 18 Mart 2022
• Fuentes, E., Fuentes, M., Alarcón, M. et al. Immune system dysfunction in the elderly. Anais da Aca-demia Brasileira de Ciências 2017; 89: 285-299.
• Alterovitz SS, Mendelsohn GA. Relationship goals of middle-aged, young-old, and old-old internet daters: An analysis of online personal ads. Journal of Aging Studies 2013; 27: 159-165.
• Yanez ND, Weiss NS, Romand J-A et al.COVID-19 mortality risk for older men and women. BMC public health 2020; 20: 1-7.
• Lithander FE, Neumann S, Tenison E et al.COVID-19 in older people: a rapid clinical review. Age and ageing 2020; 49: 501-515.
• Zinatizadeh MR, Zarandi PK, Ghiasi M et al. Immunosenescence and inflamm-ageing in COVID-19. Ageing Research Reviews 2022: 101818.
• Cunha LL, Perazzio SF, Azzi J et al. Remodeling of the immune response with aging: immunosenes-cence and its potential impact on COVID-19 immune response. Frontiers in immunology 2020; 11: 1748.
• Napoli C, Tritto I, Mansueto G et al. Immunosenescence exacerbates the COVID-19. Archives of Gerontology and Geriatrics 2020; 90: 104174.
• Lord J M, Veenith T, Sullivan J et al. Accelarated immune ageing is associated with COVID-19 disease severi-ty. Immunity & Ageing 2024; 21.1: 6.
• Gebhard C, Regitz-Zagrosek V, Neuhauser HK et al. Impact of sex and gender on COVID-19 out-comes in Eu-rope. Biol Sex Differ 2020; 11: 29.
• Mendes A, Serratrice C, Herrmann FR et al. Predictors of In-hospital mortality in older patients with COVID-19: the COVIDAge study. J Am Med Dir Assoc 2020; 21: 1546-1554.e3.
• Moradi F, Enjezab B, Ghadiri-Anari A. The role of androgens in COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14: 2003-2006.
• La Vignera S, Cannarella R, Condorelli RA et al. Sex-specific SARS-CoV-2 mortality: among hor-mone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Inter-national journal of molecular sciences 2020; 21: 2948.
• Cho SI, Yoon S, Lee H-J. Impact of comorbidity burden on mortality in patients with COVID-19 using the Kore-an health insurance database. Scientific reports 2021; 11: 6375.
• Péterfi A, Mészáros Á, Szarvas Z et al. Comorbidities and increased mortality of COVID-19 among the elder-ly: a systematic review. Physiology international 2022.
• Tucker NR, Chaffin M, Bedi Jr KC et al. Myocyte-specific upregulation of ACE2 in cardiovascular dis-ease: implications for SARS-CoV-2–mediated myocarditis. Circulation 2020; 142: 708-710.
• Fagyas M, Bánhegyi V, Úri K et al. Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardi-ovascular patients: a potential biomarker for the stratification of COVID-19 patients. Geroscience 2021; 43: 2289-2304.
• Li P, Chen L, Liu Z et al. Clinical features and short-term outcomes of elderly patients with COVID-19. Inter-national Journal of Infectious Diseases 2020; 97: 245-250.
• Sönmez U, Özdemir Y, Emecen A.S. Evaluation of Hospitalized Youngest-Old, Middle-Old and Old-est-Old COVID-19 Patients in Terms of Mortality and Risk Factors Turk Geriatri Dergisi 2023; 26.
• Zhao R, Su Z, Komissarov AA et al.Associations of D-dimer on admission and clinical features of COVID-19 patients: a systematic review, meta-analysis, and meta-regression. Frontiers in immu-nology 2021; 12: 691249.
• Berger JS, Kunichoff D, Adhikari S et al. Prevalence and outcomes of D-dimer elevation in hospital-ized pa-tients with COVID-19. Arteriosclerosis, thrombosis, and vascular biology 2020; 40: 2539-2547.